|
Video: What is a Stock Split?
|
|
Biomerica is a biomedical technology company that develops, patents, manufactures and markets diagnostic and therapeutic products used at the point-of-care (physicians' offices and over-the-counter through drugstores and online) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. Co.'s diagnostic test kits are used to analyze blood, urine, nasal or fecal material from patients in the diagnosis of various diseases, food intolerances and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in small concentrations. According to our BMRA split history records, Biomerica has had 2 splits. | |
|
Biomerica (BMRA) has 2 splits in our BMRA split history database. The first split for BMRA took place on November 14, 1994. This was a 1 for 2
reverse split, meaning for each 2
shares of BMRA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split. BMRA's second split took place on April 07, 2016.
When a company such as Biomerica conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BMRA split history from start to finish, an original position size of 1000 shares would have turned into 500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biomerica shares, starting with a $10,000 purchase of BMRA, presented on a split-history-adjusted basis factoring in the complete BMRA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$0.81 |
|
End price/share: |
$0.76 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-6.17% |
|
Average Annual Total Return: |
-0.64% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,378.29 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/14/1994 | 1 for 2
| 04/07/2016 | 1 for 1 |
|
|